Pat R. Brady
Directeur/Bestuurslid bij Twinstrand Therapeutics, Inc.
Oorsprong van het eerstegraads netwerk van Pat R. Brady
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Twinstrand Therapeutics, Inc.
 Twinstrand Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Twinstrand Therapeutics Inc. manufactures and distributes biological drugs. It focuses on discovering, developing and commercializing of therapeutics for the treatment of cancer, hepatitis A, cytomegalovirus, malaria, schistosomiasis, and fungal diseases. The company was founded in 1995 and is located in North Vancouver, Canada.
7
| Subsidiary | Pharmaceuticals: Major | 7 |
Valocor Therapeutics, Inc.
 Valocor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Valocor Therapeutics is a clinical-stage, privately-held company dedicated to developing innovative treatments for major unmet needs in dermatology. The company's portfolio of dermatology therapeutics includes Lemuteporfin, a potent and selective topical photodynamic therapy for moderate to severe acne and a portfolio of novel, topical small molecule therapeutics targeting acne, sebaceous gland hyperactivity, skin pigmentation disorders and inflammatory skin diseases. Valocor Therapeutics is headquartered in Vancouver, British Columbia. Although many common yet serious skin conditions have unsatisfactory treatment options, dermatology has in recent years attracted limited research resources and investment. As a result, a sparse pipeline and a lack of true scientific innovation have been the dominant themes of this field for the last twenty years. During this same period, technological advances have produced new research techniques that have greatly expanded its ability to study disease processes and establish new effective therapeutic strategies. Much of this innovative research has been applied to the fields such as oncology, autoimmunity, and ocular diseases. Valocor is applying current biotechnology techniques to develop breakthrough therapies for major dermatological diseases, where prevalent conditions, minimal competition and important medical needs exist.
4
| Subsidiary | Pharmaceuticals: Major | 4 |
OncoGenex Pharmaceuticals, Inc.
 OncoGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoGenex Pharmaceuticals, Inc. is a biopharmaceutical company, which engages develops and commercializes new cancer therapies that address treatment resistance in cancer patients. Its product include custirsen, apatorsen, and OGX-225. The company was founded by Martin E. Gleave and Scott Daniel Cormack in October 1991 and is headquartered in Bothell, WA.
3
| Extinct | Pharmaceuticals: Major | 3 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Pat R. Brady via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Biotechnology | President Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BIOSYNTECH, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| PNI DIGITAL MEDIA INC | Packaged Software | Corporate Officer/Principal | |
| CONSTELLATION SOFTWARE INC. | Packaged Software | Director/Board Member | |
Pender Private Investments Inc
 Pender Private Investments Inc Investment ManagersFinance Working Opportunity Fund (EVCC) Ltd seeks investment opportunities in companies located in British Columbia (Canada). The fund targets companies operating in the fields of information technology, life sciences, and clean technologies. It provides financing for early and later stage capital requirements. | Investment Managers | Director/Board Member | |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor | |
| University of British Columbia | College/University | Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal Masters Business Admin Doctorate Degree Doctorate Degree | |
| Simon Fraser University | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree | |
| DERMIRA, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
ImStar Therapeutics, Inc.
 ImStar Therapeutics, Inc. BiotechnologyHealth Technology ImStar Therapeutics, Inc. develops therapies for ALS and neurodegenerative disease. The firm's lead drug candidate is IMS-088, a small-molecule compound currently in preclinical development. It is studying compounds directed at a proprietary new therapeutic target for ALS called TANA. The company was founded by Daniel J. Wattier and Jean-Pierre Julien in 2012 and is headquartered in Vancouver, Canada. | Biotechnology | Founder Chairman | |
| University of London | College/University | Doctorate Degree Doctorate Degree | |
| ONDINE BIOMEDICAL INC. | Biotechnology | Director of Finance/CFO | |
| FIRST MAJESTIC SILVER CORP. | Precious Metals | Director/Board Member | |
Law Society of British Columbia
 Law Society of British Columbia Miscellaneous Commercial ServicesCommercial Services Law Society of British Columbia provides legal services. The firm protects the public interest in the administration of justice by setting and enforcing standards of professional conduct for lawyers. The company is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Perceptronix Medical, Inc.
 Perceptronix Medical, Inc. Medical/Nursing ServicesHealth Services Perceptronix Medical, Inc. provides cytology laboratory and cancer diagnostics services. It provides partnership opportunities for the distribution and test sales of quantitative cytology imaging machine including ClearCyte. The firm also provides software and staining kit Clear2C. Its products are used in hospitals, universities and commercial laboratories. The company was founded in 1999 and is headquartered in Vancouver, Canada. | Medical/Nursing Services | Director of Finance/CFO | |
| Kellogg School of Management | College/University | Graduate Degree | |
| AZITRA, INC. | Pharmaceuticals: Major | Chief Operating Officer | |
| Vassar College | College/University | Undergraduate Degree | |
| University of Massachusetts | College/University | Graduate Degree | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Director/Board Member | |
Regenurex Health Corp.
 Regenurex Health Corp. Food: Major DiversifiedConsumer Non-Durables Regenurex Health Corp. produces health enhancing nutritional supplements from microalgae. Its product astaxanthin serves as antioxidant and anti-inflammatory product. The company was founded by James Irwin and Shane Lander in September 2008 and is headquartered in Surrey, Canada. | Food: Major Diversified | Chief Executive Officer | |
British Columbia Bar Association
 British Columbia Bar Association Miscellaneous Commercial ServicesCommercial Services British Columbia Bar Association Operates as a law firm association to provide legal services. The company is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| GNC HOLDINGS, INC. | Specialty Stores | Director of Finance/CFO | |
| University of Saskatchewan | College/University | Graduate Degree | |
Cross-Border Impact Ventures
 Cross-Border Impact Ventures Investment ManagersFinance Cross-Border Impact Ventures (Cross-Border Impact Ventures) is a venture capital firm founded in 2019 by Megan Dover. The firm is headquartered in Toronto, Canada. | Investment Managers | Private Equity Investor | |
Topicus.com BV
 Topicus.com BV Packaged SoftwareTechnology Services Part of Topicus.com, Inc., Topicus.com BV provides vertical market software and platforms. The company is based in Deventer, Netherlands. Robin van Poelje has been the CEO of the Dutch company since 2021. | Packaged Software | Director/Board Member | |
| TOPICUS.COM INC. | Packaged Software | Director/Board Member | |
| Centurion Asset Management, Inc. | Investment Trusts/Mutual Funds | Director/Board Member | |
ViOptix, Inc.
 ViOptix, Inc. Medical SpecialtiesHealth Technology ViOptix, Inc. develops a tissue oximetry technology for the measurement of local tissue oxygen saturation. It offers T.Ox Tissue Oximeter, a lightweight and portable A/C power-operated unit. The was founded in 2009 and is headquartered in Fremont, CA. | Medical Specialties | Director/Board Member | |
Crimson Capital, Inc.
 Crimson Capital, Inc. Financial ConglomeratesFinance Crimson Capital, Inc. provides investment services. The joint venture company is based in Albany, NY. The company was founded by Roland Eschle. Linda Boland Abraham has been the CEO of the company since 2014. | Financial Conglomerates | President | |
CellAegis Devices, Inc.
 CellAegis Devices, Inc. Electronic Equipment/InstrumentsElectronic Technology CellAegis Devices, Inc. develops device for the treatment of cardiac patients. . It offers autoRIC Device, an automated noninvasive device that provides point of care delivery of remote ischemic conditioning. The company was founded by John Berton, Andrew N. Redington and Christopher Caldarone and is headquartered in Toronto, Canada. | Electronic Equipment/Instruments | Director/Board Member | |
| University of Toronto | College/University | Graduate Degree | |
| York University | College/University | Masters Business Admin | |
| University of Manitoba | College/University | Doctorate Degree | |
| ACHIEVE LIFE SCIENCES, INC. | Pharmaceuticals: Major | President |
Statistieken
Internationaal
| Canada | 31 |
| Verenigde Staten | 14 |
| Verenigd Koninkrijk | 3 |
| Nederland | 2 |
Sectoraal
| Health Technology | 16 |
| Consumer Services | 11 |
| Commercial Services | 6 |
| Finance | 6 |
| Technology Services | 5 |
Operationeel
| Director/Board Member | 41 |
| Corporate Officer/Principal | 22 |
| Chief Executive Officer | 9 |
| President | 9 |
| Undergraduate Degree | 8 |
Sterkste connecties
| Insiders | |
|---|---|
| Julia G. Levy | 22 |
| Donna Parr | 14 |
| Cindy Jacobs | 12 |
| Robert A. Fildes | 11 |
| Jeanne M. Bertonis | 11 |
| Daniel J. Wattier | 10 |
| Marjorie Co | 10 |
| Cameron Lawrence | 9 |
| Stephen Charles Anderson | 5 |
| Thor J. Borgford | 4 |
| Agnes Chan | 4 |
| Curtis A. Braun | 3 |
| David Hunt | 3 |
- Beurs
- Insiders
- Pat R. Brady
- Bedrijfsconnecties
